We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The latest update is out from Tiziana Life Sciences ( (TLSA)). On January 29, 2025, Tiziana Life Sciences received a notification from Nasdaq indicating non-compliance with the $1.00 Minimum Bid ...

VanEck Digital Transformation ETF Stock Performance Shares of NASDAQ DAPP opened at $15.41 on Friday. VanEck Digital Transformation ETF has a 52-week low of $7.10 and a 52-week high of $20.71. The ...

NASDAQ:ABL opened at $7.89 on Friday. The firm has a market capitalization of $668.13 million, a P/E ratio of -43.83 and a beta of 0.14. Abacus Life has a 1-year low of $6.75 and a 1-year high of ...

Life360, Inc. (NASDAQ:LIF – Get Free Report ... Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Life360 during the 3rd quarter valued at about $675,000.

Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 stock opened at $27.37 on Friday. Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 has a 52 week low of $24.68 and a 52 week high ...

On the other hand, the Dow registered a gain of 0.38%, and the technology-centric Nasdaq increased by 0.25%. Heading into today, shares of the company had gained 14.81% over the past month ...

Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports.

Jan. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company ... will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. Oppenheimer 35th Annual ...

Source: AN2 Therapeutics, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to ...

The metric increased 2.1% year over year, driven by robust sales in the Diagnostics and Life Sciences segments. DHR’s core sales increased 1%. Acquisitions had a positive impact of 1.5% on ...